Clinical Trial 23757

• Overview

  Study Title:

  A Randomised, Double-blind, Placebo-controlled, Phase III Study of Adjuvant Saruparib (AZD5305) in Patients with BRCAm Localised High-Risk Prostate Cancer Receiving Radiotherapy with Androgen Deprivation Therapy (EvoPAR-Prostate02)

• Treatments

  Therapies:

  Androgen deprivation therapy (ADT); PARP inhibitor

  Medications:

  ADT (); Abiraterone (); Placebo (); Saruparib ()

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.